{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T04:43:26Z","timestamp":1769057006283,"version":"3.49.0"},"reference-count":45,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T00:00:00Z","timestamp":1674604800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie, Inc.","doi-asserted-by":"publisher","award":["IME-45436"],"award-info":[{"award-number":["IME-45436"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie, Inc.","doi-asserted-by":"publisher","award":["65181879"],"award-info":[{"award-number":["65181879"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie, Inc.","doi-asserted-by":"publisher","award":["64966549"],"award-info":[{"award-number":["64966549"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie, Inc.","doi-asserted-by":"publisher","award":["CE21484"],"award-info":[{"award-number":["CE21484"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006483","name":"AbbVie, Inc.","doi-asserted-by":"publisher","award":["25005"],"award-info":[{"award-number":["25005"]}],"id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["IME-45436"],"award-info":[{"award-number":["IME-45436"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["65181879"],"award-info":[{"award-number":["65181879"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["64966549"],"award-info":[{"award-number":["64966549"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["CE21484"],"award-info":[{"award-number":["CE21484"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","award":["25005"],"award-info":[{"award-number":["25005"]}],"id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","award":["IME-45436"],"award-info":[{"award-number":["IME-45436"]}],"id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","award":["65181879"],"award-info":[{"award-number":["65181879"]}],"id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","award":["64966549"],"award-info":[{"award-number":["64966549"]}],"id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","award":["CE21484"],"award-info":[{"award-number":["CE21484"]}],"id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","award":["25005"],"award-info":[{"award-number":["25005"]}],"id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","award":["IME-45436"],"award-info":[{"award-number":["IME-45436"]}],"id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","award":["65181879"],"award-info":[{"award-number":["65181879"]}],"id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","award":["64966549"],"award-info":[{"award-number":["64966549"]}],"id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","award":["CE21484"],"award-info":[{"award-number":["CE21484"]}],"id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006436","name":"Celgene Corporation","doi-asserted-by":"publisher","award":["25005"],"award-info":[{"award-number":["25005"]}],"id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Treatment of multiple myeloma (MM) is complex; however, with equal access to care, clinical outcomes for Black patients match those in other patient groups. To reveal and begin to address clinical practice barriers to equitable, patient-centered MM care, this quality improvement (QI) initiative assessed patient electronic medical records (EMRs) and surveyed patients and providers at two large hospital systems and four community-based practices. For the educational intervention, providers participated in feedback-focused grand rounds sessions to reflect on system barriers and develop action plans to improve MM care. EMR reviews revealed infrequent documentation of cytogenetics and disease staging at community-based practices compared to large hospital systems. In surveys, providers from each care setting reported different challenges in MM care. Notably, the goals of treatment for patients and providers aligned at community clinics while providers and patients from large hospital systems had discordant perspectives. However, providers in community settings underreported race-associated barriers to care and identified different factors impacting treatment decision-making than Black patients. Relative to pre-session responses, providers were more likely to report high confidence after the educational sessions in aligning treatment decisions with guidelines and clinical evidence and shared decision-making (SDM). This QI study identified discordant perceptions among providers at large hospital systems and community-based practices in providing quality MM care. Provider education yielded increased confidence in and commitment to patient-centered care.<\/jats:p>","DOI":"10.3390\/curroncol30020123","type":"journal-article","created":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T02:29:31Z","timestamp":1674700171000},"page":"1598-1613","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multisite Quality Improvement Initiative to Identify and Address Racial Disparities and Deficiencies in Delivering Equitable, Patient-Centered Care for Multiple Myeloma\u2014Exploring the Differences between Academic and Community Oncology Centers"],"prefix":"10.3390","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9670-2864","authenticated-orcid":false,"given":"Joseph R.","family":"Mikhael","sequence":"first","affiliation":[{"name":"Translational Genomics Research Institute (TGen), City of Hope Comprehensive Cancer Center, Phoenix, AZ 85004, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6636-0741","authenticated-orcid":false,"given":"Shelby L.","family":"Sullivan","sequence":"additional","affiliation":[{"name":"PRIME Education, LLC, Fort Lauderdale, FL 33309, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey D.","family":"Carter","sequence":"additional","affiliation":[{"name":"PRIME Education, LLC, Fort Lauderdale, FL 33309, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8941-0334","authenticated-orcid":false,"given":"Cherilyn L.","family":"Heggen","sequence":"additional","affiliation":[{"name":"PRIME Education, LLC, Fort Lauderdale, FL 33309, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7664-6105","authenticated-orcid":false,"given":"Lindsay M.","family":"Gurska","sequence":"additional","affiliation":[{"name":"PRIME Education, LLC, Fort Lauderdale, FL 33309, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"5501","DOI":"10.1182\/blood-2010-07-298760","article-title":"Racial disparities in incidence and outcome in multiple myeloma: A population-based study","volume":"116","author":"Waxman","year":"2010","journal-title":"Blood"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1182\/bloodadvances.2019000308","article-title":"Racial disparities in treatment patterns and outcomes among patients with multiple myeloma: A SEER-Medicare analysis","volume":"3","author":"Ailawadhi","year":"2019","journal-title":"Blood Adv."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/cam4.2698","article-title":"Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front-line regimens using the SEER-Medicare data","volume":"9","author":"Goto","year":"2019","journal-title":"Cancer Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"pkaa034","DOI":"10.1093\/jncics\/pkaa034","article-title":"Representativeness of Black Patients in Cancer Clinical Trials Sponsored by the National Cancer Institute Compared With Pharmaceutical Companies","volume":"4","author":"Unger","year":"2020","journal-title":"JNCI Cancer Spectr."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11899-017-0393-y","article-title":"Equal treatment and outcomes for everyone with multiple myeloma: Are we there yet?","volume":"12","author":"Ailawadhi","year":"2017","journal-title":"Curr. Hematol. Malig. Rep."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1002\/cam4.1246","article-title":"Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: A SEER-medicare analysis","volume":"6","author":"Ailawadhi","year":"2017","journal-title":"Cancer Med."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/cncr.31237","article-title":"Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities","volume":"124","author":"Ailawadhi","year":"2018","journal-title":"Cancer"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41408-018-0102-7","article-title":"Disease and outcome disparities in multiple myeloma: Exploring the role of race\/ethnicity in the Cooperative Group clinical trials","volume":"8","author":"Ailawadhi","year":"2018","journal-title":"Blood Cancer J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/bloodadvances.2016002493","article-title":"Recent trends in multiple myeloma incidence and survival by age, race, and ethnicity in the United States","volume":"1","author":"Costa","year":"2017","journal-title":"Blood Adv."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/cncr.30526","article-title":"Racial disparities in treatment use for multiple myeloma","volume":"123","author":"Fiala","year":"2017","journal-title":"Cancer"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1182\/blood-2017-04-778225","article-title":"Racial and ethnic disparities in hematologic malignancies","volume":"130","author":"Kirtane","year":"2017","journal-title":"Blood"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5647","DOI":"10.1182\/blood-2018-99-119948","article-title":"Differences in Presentation and Survival Outcomes for African American Patients with Newly Diagnosed Multiple Myeloma","volume":"132","author":"Joseph","year":"2018","journal-title":"Blood"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/cncr.29160","article-title":"Disparities in black and white patients with multiple myeloma referred for autologous hematopoietic transplantation: A single center study","volume":"121","author":"Bhatnagar","year":"2014","journal-title":"Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1182\/blood.2019000406","article-title":"With equal access, African American patients have superior survival compared to white patients with multiple myeloma: A VA study","volume":"133","author":"Fillmore","year":"2019","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1200\/EDBK_238551","article-title":"Many Shades of Disparities in Myeloma Care","volume":"39","author":"Ganguly","year":"2019","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Alqazaqi, R., Schinke, C., Thanendrarajan, S., Zangari, M., Shaughnessy, J., Zhan, F., Tricot, G., van Rhee, F., and Al Hadidi, S. (2022). Geographic and Racial Disparities in Access to Chimeric Antigen Receptor\u2013T Cells and Bispecific Antibodies Trials for Multiple Myeloma. JAMA Netw. Open, 5.","DOI":"10.1001\/jamanetworkopen.2022.28877"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"LeBlanc, T., Gasparetto, C., Tuchman, S.A., Sheldon, P., Howson, A., Turell, W., Khan, Z.M., Kaura, S., and Abernethy, A.P. (2014). Exploring variations in multiple myeloma management through in-practice research. J. Clin. Oncol., 32.","DOI":"10.1200\/jco.2014.32.15_suppl.e19534"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Melas, M., Subbiah, S., Saadat, S., Rajurkar, S., and McDonnell, K.J. (2020). The Community Oncology and Academic Medical Center Alliance in the Age of Precision Medicine: Cancer Genetics and Genomics Considerations. J. Clin. Med., 9.","DOI":"10.3390\/jcm9072125"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1200\/JOP.18.00661","article-title":"Implementing Precision Medicine in Community-Based Oncology Programs: Three Models","volume":"15","author":"Levit","year":"2019","journal-title":"J. Oncol. Pract."},{"key":"ref_20","first-page":"SP425","article-title":"Implementing an oncology precision medicine clinic in a large community health system","volume":"23","author":"Thompson","year":"2017","journal-title":"Am. J. Manag. Care"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1370\/afm.562","article-title":"The Role of Academic Health Centers in Improving Health","volume":"4","author":"Roper","year":"2006","journal-title":"Ann. Fam. Med."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1146\/annurev-med-102115-021556","article-title":"Next-Generation Sequencing and Result Interpretation in Clinical Oncology: Challenges of Personalized Cancer Therapy","volume":"68","author":"Khotskaya","year":"2017","journal-title":"Annu. Rev. Med."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1089\/gtmb.2015.0061","article-title":"Next-Generation Testing for Cancer Risk: Perceptions, Experiences, and Needs Among Early Adopters in Community Healthcare Settings","volume":"19","author":"Blazer","year":"2015","journal-title":"Genet. Test. Mol. Biomark."},{"key":"ref_24","first-page":"36","article-title":"Coordinating an Oncology Precision Medicine Clinic Within an Integrated Health System: Lessons Learned in Year One","volume":"6","author":"Thompson","year":"2019","journal-title":"J. Patient-Cent. Res. Rev."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jama.1995.03530090032018","article-title":"Changing physician performance. A systematic review of the effect of continuing medical education strategies","volume":"274","author":"Davis","year":"1995","journal-title":"JAMA"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e176","DOI":"10.1097\/MCG.0000000000001535","article-title":"A Quality Improvement Initiative Is Associated With Reduced Time to Administer Biologics and Small Molecules and Emergency Room Visits in Inflammatory Bowel Disease","volume":"56","author":"Battat","year":"2022","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1097\/CEH.0000000000000102","article-title":"Comparing Patient and Provider Perceptions of Engagement and Care in Chronic Diseases","volume":"36","author":"Moreo","year":"2016","journal-title":"J. Contin. Educ. Health Prof."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1007\/s10620-016-4061-1","article-title":"Continuing Medical Education Improves Gastroenterologists\u2019 Compliance with Inflammatory Bowel Disease Quality Measures","volume":"61","author":"Sapir","year":"2016","journal-title":"Dig. Dis. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"u210329-w4679","DOI":"10.1136\/bmjquality.u210329.w4679","article-title":"Improving Interprofessional and Coproductive Outcomes of Care for Patients with Chronic Obstructive Pulmonary Disease","volume":"5","author":"Moreo","year":"2016","journal-title":"BMJ Qual. Improv. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1353\/hpu.2016.0115","article-title":"An Analysis of Race-related Attitudes and Beliefs in Black Cancer Patients: Implications for Health Care Disparities","volume":"27","author":"Penner","year":"2016","journal-title":"J. Health Care Poor Underserved"},{"key":"ref_31","first-page":"1","article-title":"Exploring behaviors, treatment beliefs, and barriers to oral chemotherapy adherence among adult leukemia patients in a rural outpatient setting","volume":"11","author":"Bohra","year":"2018","journal-title":"BMC Res. Notes"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Assari, S., Khoshpouri, P., and Chalian, H. (2019). Combined Effects of Race and Socioeconomic Status on Cancer Beliefs, Cognitions, and Emotions. Healthcare, 7.","DOI":"10.3390\/healthcare7010017"},{"key":"ref_33","first-page":"46958017727104","article-title":"Racial and Ethnic Disparities in Patient-Provider Communication With Breast Cancer Patients: Evidence From 2011 MEPS and Experiences With Cancer Supplement","volume":"54","author":"Osmani","year":"2017","journal-title":"Inq. J. Health Care Organ. Provis. Financ."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s10549-018-4776-0","article-title":"Understanding racial\/ethnic differences in breast cancer-related physical well-being: The role of patient\u2013provider interactions","volume":"170","author":"Check","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1377\/hlthaff.2010.0702","article-title":"Awareness Of Racial And Ethnic Health Disparities Has Improved Only Modestly Over A Decade","volume":"30","author":"Benz","year":"2011","journal-title":"Health Aff."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-021-08527-8","article-title":"The work of managing multiple myeloma and its implications for treatment-related decision making: A qualitative study of patient and caregiver experiences","volume":"21","author":"Pritlove","year":"2021","journal-title":"BMC Cancer"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"686165","DOI":"10.3389\/fmed.2021.686165","article-title":"Patient Preferences for Multiple Myeloma Treatments: A Multinational Qualitative Study","volume":"8","author":"Janssens","year":"2021","journal-title":"Front. Med."},{"key":"ref_38","first-page":"54","article-title":"Inadequate Awareness of and Participation in Cancer Clinical Trials in the Community Oncology Setting","volume":"33","author":"Copur","year":"2019","journal-title":"Oncology"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/1748-5908-4-63","article-title":"Improving clinical research and cancer care delivery in community settings: Evaluating the NCI community cancer centers program","volume":"4","author":"Clauser","year":"2009","journal-title":"Implement. Sci."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e350","DOI":"10.1200\/JOP.2015.005090","article-title":"Experience of the National Cancer Institute Community Cancer Centers Program on Community-Based Cancer Clinical Trials Activity","volume":"12","author":"Hirsch","year":"2016","journal-title":"J. Oncol. Pract."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s13187-014-0764-1","article-title":"Evaluating a community-partnered cancer clinical trials pilot intervention with African American communities","volume":"30","author":"Green","year":"2015","journal-title":"J. Cancer Educ."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1188\/20.CJON.439-443","article-title":"African American Patients With Multiple Myeloma: Optimizing Care to Decrease Racial Disparities","volume":"24","author":"Pierre","year":"2020","journal-title":"Clin. J. Oncol. Nurs."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-020-0284-7","article-title":"Dissecting racial disparities in multiple myeloma","volume":"10","author":"Marinac","year":"2020","journal-title":"Blood Cancer J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1158\/2643-3230.BCD-20-0123","article-title":"Recommendations on Eliminating Racial Disparities in Multiple Myeloma Therapies: A Step toward Achieving Equity in Healthcare","volume":"2","author":"Gormley","year":"2021","journal-title":"Blood Cancer Discov."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41408-022-00665-x","article-title":"Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data","volume":"12","author":"Maignan","year":"2022","journal-title":"Blood Cancer J."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/2\/123\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:15:18Z","timestamp":1760120118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/2\/123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,25]]},"references-count":45,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["curroncol30020123"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30020123","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,25]]}}}